PFE

How Investors Are Reacting To Pfizer (PFE) Easing Policy Pressures And New HHS Revenue-Sharing Deal

Earlier this month, Pfizer’s CEO Albert Bourla told investors at Morgan Stanley’s Global Healthcare Conference that major headwinds such as tariffs, drug-pricing pressures, declining COVID-19 sales and upcoming patent ex

Huge News For Pfizer Stock Fans

Pfizer Reveals Surprise HHS Revenue-Sharing Terms in Overseas Drug Pricing Deal

Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices

The US Department of Health and Human Services will get a portion of the increased revenue if Pfizer Inc. is able to charge higher drug prices abroad, according to newly released documents.

2 High-Yield Dividend Stocks to Buy and 1 to Avoid

I'd buy Energy Transfer and Verizon stocks, and avoid Pfizer.

Pfizer (PFE), What Is Drawing Fresh Attention Now?

Pfizer (PFE) heads into its Morgan Stanley Global Healthcare Conference presentation on 14 September with investors watching how management frames dividend priorities, recent pipeline setbacks, and the evolving role of n

Capitalize on the Orphan Drug Revenue Shift: Benchmark Novartis, Roche, Pfizer, Sanofi and AstraZeneca to Secure High-Value Growth Before Rivals Move First

Orphan drug demand is rising as genomics, biologics and personalized therapies advance, aided by faster approvals, government incentives, advocacy and improved rare-disease diagnosis.Dublin, Sept. 22, 2026 (GLOBE NEWSWIR

3 Dividend Stocks to Buy and Hold for 10 Years

They have a knack for increasing their dividends even when facing challenges.

Novo Sets Long-Term Targets Ahead of Semaglutide Patent Expirations

Novo Nordisk's (NVO) US-listed shares declined as the Danish drugmaker unveiled its long-term growth

What Would It Take For Pfizer To Cut Its Dividend?

Pfizer (PFE) has returned 23.1% over the past year and trades about 5% below its three-year high. Yet one question keeps coming back on its earnings calls: would it ever cut the dividend? An analyst asked it outright on